Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
No one on the platform currently holds ALLK.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-12-31 | 844,233 | $1.0M |
No one on the platform has traded ALLK yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ALLK money laundering scheme.. once done, they let these die in 3-5 yrs later . Thats it , nothing else
View on StockTwits ↗
$ALLK ive had this shit so long, but i didn't even realize it fell off my charts till today. $4500 gone. Fuck these guys.
View on StockTwits ↗
$ALLK question... what happen to traders who not sign - money lost?
View on StockTwits ↗
Wall St is expecting -0.30 EPS for $ALLK Q1 [Reporting 05/21 AMC] http://www.estimize.com/intro/allk?chart=historical&metric_name=eps&utm_c
View on StockTwits ↗
$ALLK what a scam this was. Raised close to one billion and sell it for 35 million
View on StockTwits ↗
$ALLK merger closes: Shareholders get $0.33 cash per share as Concentra takes control. Stock to be delisted effective today. Board resignations mark the end of an era for the once-promising biotech. For remaining holders, it's time to collect the check and move on. https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/ny20049047x1_8k.htm
View on StockTwits ↗
$GRYP is doing what $ALLK is doing… you can buy into ($ALLK) if you want…. $ALLK TARGET Projection $8🎯
View on StockTwits ↗
@Beetle_juice67 @MichaelSctock it’s ok atleast we’re not $ALLK
View on StockTwits ↗Wall St is expecting -0.30 EPS for $ALLK Q1 [Reporting 05/14 AMC] http://www.estimize.com/intro/allk?chart=historical&metric_name=eps&utm_c
View on StockTwits ↗Wall St is expecting -0.19 EPS for $ALLK Q2 [Reporting 08/06 AMC] http://www.estimize.com/intro/allk?chart=historical&metric_name=eps&utm_c
View on StockTwits ↗
$SUNE and $ALLK have the least movement in my portfolio 😡 🧐 🤔
View on StockTwits ↗
$ALLK On 12/5 Institutional Shares were 73,756,678 - 82.55% and today (4/15) Institutional Shares are now 75,318,708 - 84.30% 🤙
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $0 | — | $-0.33 | $-0.33–$-0.33 | — | 1 |
| 2027 | $225M | — | $-0.25 | $-0.42–$-0.08 | — | 2 |
| 2028 | $189M | -15.9% | $-0.17 | $-0.17–$-0.17 | — | 1 |
| 2029 | $11M | -94.1% | $-0.20 | $-0.20–$-0.20 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-05-07 | $-0.26 | $-0.29 | -11.5% |
| 2025-03-12 | $-0.21 | $0.00 | +102.0% |
| 2024-11-06 | $-0.22 | $-0.21 | +4.5% |
| 2024-08-07 | $-0.32 | $-0.30 | +6.3% |
| 2024-05-09 | $-0.41 | $-0.50 | -22.0% |
| 2024-03-14 | $-0.53 | $-0.71 | -34.0% |
| 2023-11-13 | $-0.46 | $-0.52 | -13.0% |
| 2023-08-09 | $-0.49 |
| $-0.41 |
| +16.3% |
| $28M |
| — |
| HARPHarpoon Therapeutics, Inc. | $23.01 | +0.09% | $865M | — |
| KAKineta, Inc. | $0.57 | -30.77% | $7M | — |
Source: Financial Modeling Prep · peers by sector/industry